Stock A142760 MOA LIFE PLUS CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News MOA Life Plus Co. Ltd.

Equities

A142760

KR7142760008

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
2,335 KRW -4.30% Intraday chart for MOA Life Plus Co. Ltd. -29.24% +9.62%
Apr. 15 Bioleaders Corporation announced that it has received KRW 10 billion in funding from Moadata Co., Ltd. CI
Mar. 29 Bioleaders Corporation announced that it has received KRW 15 billion in funding CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bioleaders Corporation announced that it has received KRW 10 billion in funding from Moadata Co., Ltd.
CI
Bioleaders Corporation announced that it has received KRW 15 billion in funding
CI
Youngchul Park completed the acquisition of 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation.
CI
Moadata Co., Ltd. completed the acquisition of 6.95% stake in Bioleaders Corporation from Youngchul Park.
CI
Bioleaders Corporation announced that it expects to receive KRW 15 billion in funding
CI
Moadata Co., Ltd. agreed to acquire a 6.95% stake in Bioleaders Corporation from Youngchul Park for KRW 15.3 billion
CI
Bioleaders Corporation announced that it expects to receive KRW 10 billion in funding from Moadata Co., Ltd.
CI
Youngchul Park agreed to acquire 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation for KRW 9.3 billion.
CI
Bioleaders Corporation announced that it has received KRW 2 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.
CI
An unknown buyer agreed to acquire 20.25052% stake in Anyone F&C Co., Ltd. from Bioleaders Corporation for KRW9.9 billion.
CI
Bioleaders Corporation announced that it expects to receive KRW 2 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.
CI
Bioleaders Corporation(KOSDAQ:A142760) dropped from S&P Global BMI Index
CI
Bioleaders Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Next Bt Co., Ltd. announced that it has received KRW 6 billion in funding from Bioleaders Corporation, Dk Life Science Co., Ltd. and other investors
CI
Bioleaders Corporation announced that it has received KRW 13 billion in funding from Blash Asset Management Co., Ltd, Tiger Asset Management Discretionary Investment Co., Ltd., and other investors
CI
Bioleaders Corporation announced that it has received KRW 8 billion in funding
CI
Bioleaders Corporation announced that it expects to receive KRW 8 billion in funding from Blash Asset Management Co., Ltd, Tiger Asset Management Discretionary Investment Co., Ltd., and other investors
CI
Bioleaders Corporation announced that it expects to receive KRW 8 billion in funding
CI
Next Bt Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Bioleaders Corporation, Dk Life Science Co., Ltd. and other investors
CI
Bioleaders Corporation announced that it has received KRW 13 billion in funding from C-Square Asset Management, A One Asset Management Co., Ltd, Bluetech Asset Management Co., Ltd., Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm and other investors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A142760 Stock
  4. News MOA Life Plus Co. Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW